Philip Vickers

Philip Vickers

Director/Board Member bei AVROBIO, INC.

Vermögen: 6 144 $ am 31.03.2024

64 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Philip J.
Vickers
is currently the President & Chief Executive Officer at Solu Therapeutics, Inc. He is also an Independent Director at Avrobio, Inc. and a Director at Northern Mosaic LP.
Previously, he held positions such as President, Chief Executive Officer & Director at Northern Biologics, Inc. from 2017 to 2020, President, Chief Executive Officer & Director at Faze Medicines, Inc. from 2021 to 2022, President, Director & Chief Scientific Officer at Resolvyx Pharmaceuticals, Inc. from 2009 to 2011, and Global Head-Research & Development at Shire Plc from 2013 to 2017.
He has also served as an Independent Director at Revance Therapeutics, Inc. from 2015 to 2023.
Additionally, he has held positions at Neusentis Ltd., Boehringer Ingelheim Corp., Pfizer (St. Louis), and Merck Research Laboratories Massachusetts LLC.
Dr. Vickers completed his undergraduate degree at the University of Salford and obtained a doctorate degree from the University of Toronto.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
07.03.2024 4 800 ( 0,01% ) 6 144 $ 31.03.2024

Aktive Positionen von Philip Vickers

UnternehmenPositionBeginn
AVROBIO, INC. Director/Board Member 07.01.2019
Director/Board Member -
Chief Executive Officer -
Alle aktiven Positionen von Philip Vickers

Ehemalige bekannte Positionen von Philip Vickers

UnternehmenPositionEnde
REVANCE THERAPEUTICS, INC. Director/Board Member 03.05.2023
Chief Executive Officer 01.11.2022
Chief Executive Officer 01.12.2020
SHIRE Chief Tech/Sci/R&D Officer 01.06.2017
President 01.01.2011
Sehen Sie sich die Erfahrung von Philip Vickers im Detail an

Ausbildung von Philip Vickers

University of Salford Undergraduate Degree
University of Toronto Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Philip Vickers im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
REVANCE THERAPEUTICS, INC.

Health Technology

AVROBIO, INC.

Health Technology

Private Unternehmen10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Philip Vickers